New brain cancer vaccine trial seeks to train immune system

NCT ID NCT06622434

Recruiting now Disease control Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

Summary

This study is testing a new vaccine designed to help the body's immune system fight glioblastoma, a serious brain cancer. It will be given to 35 patients who have already received standard surgery and radiation/chemotherapy. The main goals are to find a safe dose and see if the vaccine successfully activates the patient's immune cells against the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Neurology, Hopital Saint louis (APHP)
RECRUITING

Paris, 75010, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Department of Neurology, Hopital de la Salpêtrière
RECRUITING

Paris, Idf, 75013, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Department of Neurology, University Hospital of Besançon
NOT_YET_RECRUITING

Besançon, Bourgogne-Franche-Comté, 25030, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Medical Oncology Department, Eugène Marquis Centre
NOT_YET_RECRUITING

Rennes, Brittany Region, 35000, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Neuro-oncology Department, La Timone Hospital
NOT_YET_RECRUITING

Marseille, Provence-Alpes-Côte d'Azur Region, 13005, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEWLY DIAGNOSED GLIOBLASTOMA